|
Lantheus Holdings, Inc. (LNTH) Avaliação DCF
US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Lantheus Holdings, Inc. (LNTH) Bundle
Economize tempo e melhore a precisão com a nossa calculadora DCF (LNTH)! Utilizando dados reais da Lantheus Holdings, Inc. e suposições personalizáveis, essa ferramenta permite que você preveja, analise e valorize o Lantheus como um investidor experiente.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 339.4 | 425.2 | 935.1 | 1,296.4 | 1,533.9 | 1,510.0 | 1,486.4 | 1,463.2 | 1,440.3 | 1,417.8 |
| Revenue Growth, % | 0 | 25.28 | 119.91 | 38.65 | 18.32 | -1.56 | -1.56 | -1.56 | -1.56 | -1.56 |
| EBITDA | 22.7 | -25.0 | 81.8 | 491.0 | 515.3 | 244.7 | 240.9 | 237.1 | 233.4 | 229.8 |
| EBITDA, % | 6.68 | -5.88 | 8.75 | 37.87 | 33.59 | 16.2 | 16.2 | 16.2 | 16.2 | 16.2 |
| Depreciation | 24.7 | 42.3 | 47.9 | 60.0 | 64.6 | 94.2 | 92.7 | 91.3 | 89.8 | 88.4 |
| Depreciation, % | 7.27 | 9.95 | 5.13 | 4.63 | 4.21 | 6.24 | 6.24 | 6.24 | 6.24 | 6.24 |
| EBIT | -2.0 | -67.3 | 33.9 | 431.0 | 450.6 | 150.5 | 148.1 | 145.8 | 143.6 | 141.3 |
| EBIT, % | -0.58926 | -15.82 | 3.63 | 33.24 | 29.38 | 9.97 | 9.97 | 9.97 | 9.97 | 9.97 |
| Total Cash | 79.6 | 98.5 | 415.7 | 713.7 | 912.8 | 621.0 | 611.3 | 601.7 | 592.4 | 583.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 54.0 | 89.3 | 213.4 | 284.3 | 321.3 | 309.9 | 305.0 | 300.3 | 295.6 | 291.0 |
| Account Receivables, % | 15.91 | 21.01 | 22.82 | 21.93 | 20.94 | 20.52 | 20.52 | 20.52 | 20.52 | 20.52 |
| Inventories | 35.7 | 35.1 | 35.5 | 64.0 | 68.0 | 96.5 | 95.0 | 93.5 | 92.1 | 90.6 |
| Inventories, % | 10.53 | 8.26 | 3.79 | 4.94 | 4.43 | 6.39 | 6.39 | 6.39 | 6.39 | 6.39 |
| Accounts Payable | 16.3 | 20.8 | 20.6 | 41.2 | 34.6 | 52.3 | 51.5 | 50.7 | 49.9 | 49.1 |
| Accounts Payable, % | 4.8 | 4.89 | 2.2 | 3.18 | 2.25 | 3.46 | 3.46 | 3.46 | 3.46 | 3.46 |
| Capital Expenditure | -12.5 | -12.1 | -18.3 | -46.6 | -51.6 | -46.7 | -45.9 | -45.2 | -44.5 | -43.8 |
| Capital Expenditure, % | -3.68 | -2.86 | -1.96 | -3.59 | -3.37 | -3.09 | -3.09 | -3.09 | -3.09 | -3.09 |
| Tax Rate, % | 27.5 | 27.5 | 27.5 | 27.5 | 27.5 | 27.5 | 27.5 | 27.5 | 27.5 | 27.5 |
| EBITAT | -2.3 | -63.9 | 35.6 | 342.6 | 326.7 | 134.5 | 132.4 | 130.4 | 128.3 | 126.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -63.6 | -64.0 | -59.4 | 277.2 | 292.1 | 182.7 | 184.8 | 181.9 | 179.0 | 176.2 |
| WACC, % | 6.42 | 6.4 | 6.42 | 6.36 | 6.34 | 6.39 | 6.39 | 6.39 | 6.39 | 6.39 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 755.1 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 183 | |||||||||
| Terminal Value | 7,681 | |||||||||
| Present Terminal Value | 5,636 | |||||||||
| Enterprise Value | 6,391 | |||||||||
| Net Debt | -912 | |||||||||
| Equity Value | 7,303 | |||||||||
| Diluted Shares Outstanding, MM | 72 | |||||||||
| Equity Value Per Share | 101.92 |
What You Will Receive
- Comprehensive Financial Model: Lantheus Holdings, Inc.'s (LNTH) actual data facilitates accurate DCF valuation.
- Complete Forecast Customization: Modify revenue growth, profit margins, WACC, and other crucial metrics.
- Real-Time Calculations: Automatic updates provide immediate feedback as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation analysis.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- Real-Life LNTH Data: Pre-filled with Lantheus Holdings’ historical financials and forward-looking projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
- Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
- User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.
How It Works
- Download the Template: Gain immediate access to the Excel-based LNTH DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Lantheus Holdings’ intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis decisions.
Why Choose This Calculator for Lantheus Holdings, Inc. (LNTH)?
- Accuracy: Utilizes real Lantheus financial data for precise calculations.
- Flexibility: Allows users to easily adjust and test various inputs.
- Time-Saving: Eliminate the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and standards of CFOs in mind.
- User-Friendly: Intuitive design makes it accessible for users with limited financial modeling knowledge.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for analyzing Lantheus Holdings, Inc. (LNTH) in the biotech sector.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the healthcare industry.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Lantheus Holdings, Inc. (LNTH).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to the biotech field.
- Biotech Enthusiasts: Gain insights into how companies like Lantheus Holdings, Inc. (LNTH) are valued in the market.
What the Template Contains
- Preloaded LNTH Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.